De Novo CD5 diffuse large B-cell llymphoma with cutaneous involvement

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11140%2F14%3A10282463" target="_blank" >RIV/00216208:11140/14:10282463 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.1097/PCR.0000000000000046" target="_blank" >http://dx.doi.org/10.1097/PCR.0000000000000046</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1097/PCR.0000000000000046" target="_blank" >10.1097/PCR.0000000000000046</a>

Result language
angličtina
Original language name
De Novo CD5 diffuse large B-cell llymphoma with cutaneous involvement
Original language description
De novo CD5+ diffuse large B-cell lymphoma (DLBCL) is rare but distinctive clinicopathologic variant of DLBCL mainly affecting elderly people, showing female predilection and characterized by poor survival and outcome with conventional therapy. The maindifferential diagnoses include secondary CD5+ DLBCL (acquisition of CD5 expression during the progression of DLBCL or follicular lymphoma), large cell transformation in B-cell chronic lymphocytic leukemia (Richter syndrome), and mantle cell lymphoma. Extranodal involvement is often seen, but cutaneous involvement in this lymphoma variant is unusual.
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FP - Other medical fields
OECD FORD branch
—

Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2014
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)